Use access key #2 to skip to page content.
$80.62 -6.91 (-7.89%)
10/6/2008 4:00 PM

Genentech, Inc. (DNA)

CAPS Rating:
****

The Company is a biotechnology company that discovers, develops, manufactures, and commercializes biotherapeutics for unmet medical needs.

View All Commentary (DNA)

Recs

0

Avatar brianjac (< 20) Submitted: 5/07/08 7:35 AM : Outperform Start Price: $68.24 DNA Score: 44.37

Solid company with steadily increasing earnings, solid balance sheet, and great pipeline of potential blockbuster drugs that just got beaten up by bad news. Back at 80 very soon.

Report this Post Replies: 0 | Reply

Featured Broker Partners